Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesImage ProcessingCan AI salvage suboptimal CT studies?AI-based image enhancement improves diagnostic acceptability of suboptimal chest CT and CT pulmonary angiography exams.People in the NewsRadiologist blends clinical knowledge with visual storytellingMRIMRI safety regulation: Lessons from ionizing radiation standardsServiceRight to repair standoff continuesMRI‘Dark-light-dark sign’ on MRI predicts rectal cancer metastasis